|
|
Publication
|
| Title of Article |
Buparlisib and ponatinib inhibit aggressiveness of cholangiocarcinoma cells via suppression of IRS1-related pathway by targeting oxidative stress resistance |
| Date of Acceptance |
9 October 2024 |
| Journal |
| Title of Journal |
Biomedicine & Pharmacotherapy |
| Standard |
SCOPUS Tier 1 |
| Institute of Journal |
ELSEVIER |
| ISBN/ISSN |
|
| Volume |
2024 |
| Issue |
180 |
| Month |
|
| Year of Publication |
2024 |
| Page |
117569 |
| Abstract |
|
| Keyword |
Bile duct cancer, Targeted therapy, Buparlisib, Ponatinib, Anti-cancer, Insulin receptor substrate 1 |
| Author |
|
| Reviewing Status |
มีผู้ประเมินอิสระ |
| Status |
ตีพิมพ์แล้ว |
| Level of Publication |
นานาชาติ |
| citation |
true |
| Part of thesis |
true |
| ใช้สำหรับสำเร็จการศึกษา |
ไม่เป็น |
| Attach file |
|
| Citation |
0
|
|
|
|
|
|
|
|
|
Journal Publication
ไทย